Insider Trading activities of Vertex Pharmaceuticals Inc / Ma insiders. , Part 9

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vertex Pharmaceuticals Inc / Ma since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vertex Pharmaceuticals Inc / Ma since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Vertex Pharmaceuticals Inc / Ma since 2005. The reporting company's ticker symbol is VRTX. The reporting company's CIK number is 875320.
The total value of stock buying since 2005 is $3,407,145.
The total value of stock sales since 2005 is $897,863,714.
The total value of stock option exercises since 2005 is $287,013,220.



Table 2. Detailed insider stock purchases, sales, and option exercises of Vertex Pharmaceuticals Inc / Ma insiders (VRTX) , Part 9
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-09-16 Boger Joshua S (Director) Sale 6,400 36.83 235,712
2009-09-16 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-09-09 Boger Joshua S (Director) Sale 6,400 37.00 236,800
2009-09-09 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-09-01 Boger Joshua S (Director) Sale 6,400 37.38 239,200
2009-09-01 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-08-25 Boger Joshua S (Director) Sale 6,400 36.75 235,200
2009-08-25 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-08-19 Boger Joshua S (Director) Sale 6,400 35.57 227,648
2009-08-19 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-08-14 Silva Paul M (V.P. and Corporate Controller) Sale 750 33.99 25,492
2009-08-12 Boger Joshua S (Director) Sale 6,400 34.19 218,816
2009-08-12 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-08-05 Boger Joshua S (Director) Sale 6,400 37.11 237,504
2009-08-05 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-08-03 Kelly Lisa (SVP, Human Resources) Sale 319 36.09 11,512
2009-08-03 Boger Kenneth S (SVP & General Counsel) Sale 20,844 36.02 750,800
2009-08-03 Boger Kenneth S (SVP & General Counsel) Option Ex 20,844 17.95 374,254
2009-07-29 Boger Joshua S (Director) Sale 6,400 36.36 232,704
2009-07-29 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-07-28 Boger Kenneth S (SVP & General Counsel) Sale 19,898 36.00 716,328
2009-07-28 Boger Kenneth S (SVP & General Counsel) Option Ex 19,898 15.44 307,225
2009-07-27 Silva Paul M (V.P. and Corporate Controller) Sale 125 35.68 4,460
2009-07-22 Boger Joshua S (Director) Sale 6,400 34.25 219,200
2009-07-22 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-07-20 Graves Kurt (EVP, Chief Commercial Officer) Sale 3,868 33.47 129,461
2009-07-15 Mueller Peter (EVP Global R&D, CSO) Sale 2,400 32.88 78,912
2009-07-15 Mueller Peter (EVP Global R&D, CSO) Option Ex 2,400 9.69 23,256
2009-07-15 Boger Joshua S (Director) Sale 6,400 32.92 210,688
2009-07-15 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-07-09 Boger Joshua S (Director) Sale 6,400 33.42 213,888
2009-07-09 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-07-01 Boger Joshua S (Director) Sale 6,400 34.71 222,144
2009-07-01 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-06-26 Boger Kenneth S (SVP & General Counsel) Sale 108,001 36.00 3,888,036
2009-06-26 Boger Kenneth S (SVP & General Counsel) Option Ex 108,001 13.86 1,496,461
2009-06-24 Boger Joshua S (Director) Sale 6,400 33.90 216,960
2009-06-24 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-06-17 Boger Joshua S (Director) Sale 12,800 31.94 408,832
2009-06-17 Boger Joshua S (Director) Option Ex 12,800 13.11 167,808
2009-06-15 Mueller Peter (EVP Global R&D, CSO) Sale 2,400 31.02 74,448
2009-06-15 Mueller Peter (EVP Global R&D, CSO) Option Ex 2,400 9.69 23,256
2009-06-12 Cordes Eugene (Director) Sale 2,000 31.16 62,320
2009-06-10 Boger Joshua S (Director) Sale 6,400 30.12 192,768
2009-06-10 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-06-03 Boger Joshua S (Director) Sale 6,400 31.41 201,024
2009-06-03 Boger Joshua S (Director) Option Ex 6,400 13.11 83,904
2009-05-27 Boger Joshua S (Director) Sale 26,900 29.44 791,936
2009-05-26 Boger Joshua S (Director) Sale 26,900 29.12 783,328
2009-05-18 Silva Paul M (V.P. and Corporate Controller) Sale 468 28.44 13,309
2009-05-18 Sachdev Amit (SVP, Corp Affairs & Pub Policy) Sale 783 28.44 22,268
2009-05-18 Graves Kurt (EVP, Chief Commercial Officer) Sale 925 28.44 26,307
2009-05-18 Garrison Richard C (SVP and Catalyst) Sale 532 28.45 15,135
2009-05-18 Smith Ian F (EVP & CFO) Sale 925 28.44 26,307
2009-05-18 Sanders Charles A (Director) Sale 3,333 28.44 94,790
2009-05-18 Sanders Charles A (Director) Option Ex 3,333 10.05 33,496
2009-05-15 Mueller Peter (EVP Global R&D, CSO) Sale 2,400 28.56 68,544
2009-05-15 Mueller Peter (EVP Global R&D, CSO) Option Ex 2,400 9.69 23,256
2009-05-11 Sanders Charles A (Director) Sale 3,333 30.41 101,356
2009-05-11 Sanders Charles A (Director) Option Ex 3,333 10.05 33,496
2009-05-07 Mueller Peter (EVP, Global R&D, CSO) Sale 12,796 28.94 370,316
2009-05-07 Smith Ian F (EVP & CFO) Sale 32,500 28.90 939,250
2009-05-07 Boger Joshua S (CEO) Sale 22,050 28.95 638,347
2009-05-07 Boger Kenneth S (SVP & General Counsel) Sale 11,826 28.89 341,653
2009-05-04 Sanders Charles A (Director) Sale 3,334 30.08 100,286
2009-05-04 Sanders Charles A (Director) Option Ex 3,334 10.05 33,506
2009-04-28 Graves Kurt (EVP, Chief Commercial Officer) Sale 2,507 32.00 80,224
2009-04-21 Graves Kurt (EVP, Chief Commercial Officer) Sale 493 27.03 13,325
2009-04-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 2,400 26.98 64,752
2009-04-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Option Ex 2,400 9.69 23,256
2009-04-15 Sachs Bruce I (Director) Sale 10,000 26.98 269,800
2009-04-15 Sachs Bruce I (Director) Option Ex 10,000 10.05 100,500
2009-03-19 Lewis-hall Freda C (EVP, Medicines Development) Sale 1,250 29.11 36,387
2009-03-16 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 2,400 28.52 68,436
2009-03-16 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Option Ex 2,400 9.69 23,256
2009-02-17 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 2,400 32.88 78,912
2009-02-17 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Option Ex 2,400 9.69 23,256
2009-02-09 Silva Paul M (V.P. and Corporate Controller) Sale 250 33.69 8,422
2009-02-06 Smith Ian F (EVP & CFO) Sale 41,212 35.00 1,442,420
2009-02-06 Smith Ian F (EVP & CFO) Option Ex 41,212 12.43 512,100
2009-02-04 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 1,118 33.81 37,799
2009-02-04 Smith Ian F (EVP & CFO) Sale 2,850 33.81 96,358
2009-01-29 Brandt Eric (Director) Sale 27,500 33.00 907,500
2009-01-29 Brandt Eric (Director) Option Ex 27,500 11.15 306,762
2009-01-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 2,400 29.63 71,112
2009-01-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Option Ex 2,400 9.07 21,768
2008-12-19 Lewis-hall Freda C (EVP, Medicines Development) Sale 1,250 29.90 37,375
2008-12-15 Garrison Richard C (SVP and Catalyst) Sale 1,975 25.02 49,414
2008-12-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 2,400 25.81 61,944
2008-12-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Option Ex 2,400 9.07 21,768
2008-12-11 Lewis-hall Freda C (EVP, Medicines Development) Sale 1,098 26.00 28,548
2008-12-10 Lewis-hall Freda C (EVP, Medicines Development) Sale 152 26.00 3,952
2008-12-03 Boger Joshua S (President & CEO) Sale 12,000 22.85 274,236
2008-12-03 Boger Joshua S (President & CEO) Option Ex 12,000 13.63 163,560
2008-11-26 Boger Joshua S (President & CEO) Sale 13,000 24.33 316,290
2008-11-26 Boger Joshua S (President & CEO) Option Ex 13,000 13.63 177,190
2008-11-19 Boger Joshua S (President & CEO) Sale 13,000 25.46 330,980
2008-11-19 Boger Joshua S (President & CEO) Option Ex 13,000 13.63 177,190
2008-11-18 Silva Paul M (V.P. and Corporate Controller) Sale 218 26.13 5,696
2008-11-18 Sachdev Amit (SVP, Public Policy,Gov Affairs) Sale 791 26.20 20,724
2008-11-18 Graves Kurt (EVP, Chief Commercial Officer) Sale 379 26.10 9,891
2008-11-18 Garrison Richard C (SVP and Catalyst) Sale 86 26.12 2,246
2008-11-18 Smith Ian F (EVP & CFO) Sale 16 26.18 418
2008-11-18 Boger Kenneth S (SVP & General Counsel) Sale 15,000 26.69 400,350
2008-11-17 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 2,400 27.14 65,136
2008-11-17 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Option Ex 2,400 9.07 21,768
2008-11-12 Boger Joshua S (President & CEO) Sale 13,000 26.77 348,010
2008-11-12 Boger Joshua S (President & CEO) Option Ex 13,000 13.63 177,190
2008-11-05 Boger Joshua S (President & CEO) Sale 13,000 27.97 363,610
2008-11-05 Boger Joshua S (President & CEO) Option Ex 13,000 13.63 177,190
2008-10-29 Boger Joshua S (President & CEO) Sale 13,000 21.96 285,480
2008-10-29 Boger Joshua S (President & CEO) Option Ex 13,000 13.63 177,190
2008-10-22 Boger Joshua S (President & CEO) Sale 5,600 22.88 128,128
2008-10-22 Boger Joshua S (President & CEO) Option Ex 13,000 13.63 177,190
2008-10-21 Graves Kurt (EVP, Chief Commercial Officer) Sale 970 25.65 24,880
2008-10-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 2,400 26.77 64,248
2008-10-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Option Ex 2,400 9.07 21,768
2008-10-15 Boger Joshua S (President & CEO) Sale 20,400 25.12 519,844
2008-10-15 Boger Joshua S (President & CEO) Option Ex 13,000 13.63 177,190
2008-10-01 Alam John J (EVP, Med. Dev. Group & CMO) Sale 4,253 32.65 138,860
2008-10-01 Alam John J (EVP, Med. Dev. Group & CMO) Option Ex 4,253 13.63 57,968
2008-09-17 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 2,400 27.94 67,056
2008-09-17 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Option Ex 2,400 9.07 21,768
2008-09-10 Boger Joshua S (President & CEO) Sale 12,778 26.55 339,192
2008-09-10 Boger Joshua S (President & CEO) Option Ex 12,778 10.19 130,207
2008-09-10 Alam John J (EVP, Med. Dev. Group & CMO) Sale 6,614 26.23 173,485
2008-09-10 Alam John J (EVP, Med. Dev. Group & CMO) Option Ex 6,614 10.19 67,396
2008-09-03 Boger Joshua S (President & CEO) Sale 12,400 25.93 321,532
2008-09-03 Boger Joshua S (President & CEO) Option Ex 12,400 10.19 126,356
2008-09-03 Alam John J (EVP, Med. Dev. Group & CMO) Sale 6,612 25.86 170,986
2008-09-03 Alam John J (EVP, Med. Dev. Group & CMO) Option Ex 6,612 10.19 67,376
2008-08-27 Boger Joshua S (President & CEO) Sale 12,400 27.03 335,172
2008-08-27 Boger Joshua S (President & CEO) Option Ex 12,400 10.19 126,356
2008-08-27 Alam John J (EVP, Med. Dev. Group & CMO) Sale 6,612 27.02 178,656
2008-08-27 Alam John J (EVP, Med. Dev. Group & CMO) Option Ex 6,612 10.19 67,376
2008-08-20 Boger Joshua S (President & CEO) Sale 12,400 27.39 339,673
2008-08-20 Boger Joshua S (President & CEO) Option Ex 12,400 10.19 126,356
2008-08-20 Alam John J (EVP, Med. Dev. Group & CMO) Sale 6,612 27.70 183,119
2008-08-20 Alam John J (EVP, Med. Dev. Group & CMO) Option Ex 6,612 10.19 67,376
2008-08-13 Boger Joshua S (President & CEO) Sale 12,400 29.36 364,064
2008-08-13 Boger Joshua S (President & CEO) Option Ex 12,400 10.19 126,356
2008-08-06 Boger Joshua S (President & CEO) Sale 12,400 30.93 383,532
2008-08-06 Boger Joshua S (President & CEO) Option Ex 12,400 10.19 126,356
2008-07-30 Boger Joshua S (President & CEO) Sale 12,400 32.65 404,798
2008-07-30 Boger Joshua S (President & CEO) Option Ex 12,400 10.19 126,356
2008-07-21 Graves Kurt (EVP, Chief Commercial Officer) Sale 2,925 32.30 94,477
2008-07-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Sale 2,400 32.40 77,760
2008-07-15 Mueller Peter (EVP Drug Innov.& Realiz, CSO) Option Ex 2,400 9.07 21,768
2008-07-09 Smith Ian F (EVP & CFO) Sale 81,436 35.00 2,850,260
2008-07-09 Smith Ian F (EVP & CFO) Option Ex 81,436 16.08 1,309,653

Insider trading activities including stock purchases, stock sales, and option exercises of VRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vertex Pharmaceuticals Inc / Ma (symbol VRTX, CIK number 875320) see the Securities and Exchange Commission (SEC) website.